MIRA Pharmaceuticals, Inc. (MIRA) Operating cash flow 2022–2025
MIRA Pharmaceuticals, Inc. (MIRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.7MFY2025 · since FY2022: -$5.6M → -$4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.7M | +16.2% |
| FY2024 | -$5.6M | -22.7% |
| FY2023 | -$4.5M | +19.1% |
| FY2022 | -$5.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MIRA financial trends
MIRA RevenueMIRA Net incomeMIRA Net marginMIRA Gross profitMIRA Gross marginMIRA Operating incomeMIRA Operating marginMIRA Free cash flowMIRA Capital expendituresMIRA Return on equityMIRA Stock buybacksMIRA Dividends paidMIRA Total assetsMIRA Total liabilitiesMIRA Shareholders’ equityMIRA overview →